Novel mutation in the PML/RARα chimeric gene exhibits dramatically decreased ligand-binding activity and confers acquired resistance to retinoic acid in acute promyelocytic leukemia
- 1 July 2001
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 29 (7) , 864-872
- https://doi.org/10.1016/s0301-472x(01)00651-8
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APLNature Genetics, 1998
- Differential Role of Homologous Positively Charged Amino Acid Residues for Ligand Binding in Retinoic Acid Receptor α Compared with Retinoic Acid Receptor βPublished by Elsevier ,1997
- Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acidNature, 1995
- Itraconazole and retinoid resistanceAmerican Journal of Hematology, 1995
- Alteration in the Retinoid Specificity of Retinoic Acid Receptor-β by Site-directed Mutagenesis of Arg269 and Lys220Published by Elsevier ,1995
- The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cellsCell, 1993
- Immunodetection of multiple species of retinoic acid receptor α: Evidence for phosphorylationExperimental Cell Research, 1992
- Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PMLCell, 1991
- The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locusNature, 1990
- Identification of a receptor for the morphogen retinoic acidNature, 1987